首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Note: Comparative Prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as Etiologic Agents of Histologically Identified Intestinal Spirochetosis in Australia
【2h】

Note: Comparative Prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as Etiologic Agents of Histologically Identified Intestinal Spirochetosis in Australia

机译:注意:作为澳大利亚在组织学上确定为肠道螺旋藻病的病原体巴西短螺旋体和短螺旋体(Serpulina)pilosicoli的比较患病率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA from gastrointestinal biopsy specimens from 28 Australian patients with histologic evidence of intestinal spirochetosis (IS) was subjected to PCRs to amplify segments of the 16S rRNA and NADH oxidase genes of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli. B. aalborgi was identified in specimens from 24 (85.7%) patients and B. pilosicoli in those from 4 (14.3%) patients (2 of whom were also positive for B. aalborgi). For two patients, no product was amplified. This study demonstrates that B. aalborgi is much more commonly involved in histologically identified IS in Australian patients than is B. pilosicoli. This is the first report of amplification of B. pilosicoli DNA from humans with IS.
机译:对来自28例澳大利亚患者的胃肠道活检标本的DNA进行了肠道螺旋体病(IS)的组织学检查,对其PCR进行扩增,以扩增a.borchyspira aalborgi和Brachyspira(Serpulina)pilosicoli的16S rRNA和NADH氧化酶基因的片段。在24例(85.7%)患者的标本中鉴定出了B. aalborgi,在4例(14.3%)患者的标本中鉴定了B. pilosicoli(其中2例也对B. aalborgi呈阳性)。对于两名患者,没有产物被扩增。这项研究表明,在澳大利亚患者中,A.borborgi比B. pilosicoli更常参与组织学鉴定的IS。这是首次从患有IS的人类中扩增pilosicoli DNA的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号